Clinical Trials Directory

Trials / Completed

CompletedNCT03005483

Gabapentin as Adjuvant for Postoperative Pain in Pediatric Orthopedic Surgery

Placebo Controlled, Randomized,Gabapentin as Adjuvant for Postoperative Pain in Pediatric Orthopedic Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Hospital Infantil Albert Sabin · Academic / Other
Sex
All
Age
3 Months – 16 Years
Healthy volunteers
Accepted

Summary

This study is a clinical trial, prospective, randomized and double-blinded. Gabapentin oral 10 mg/kg was administered to reduce the pain intensity as well as the opioid consumption in children from 3 months to 16 years submitted unilateral limb surgery.

Detailed description

This study is a clinical trial, prospective, randomized and double-blinded. Gabapentin oral 10 mg/kg was administered to reduce the pain intensity as well as the opioid consumption in children from 3 months to 16 years submitted unilateral limb surgery. The children were divided into 2 groups: the gabapentin group (GG) was administered gabapentin 1 to 2 hours before procedure (N-40) and the placebo group (GP) was administered placebo 1 to 2 hours before surgery (N-44). Both groups were subjected to the same general anesthesia protocol, opioid free, and femoral and sciatic block with bupivacaine 0.125%. All patients received dipyrone and rescue analgesic used was morphine into 2/2h. The variables studied were age, gender, weight, type of surgery, hemodynamics, postoperative pain and morphine consumption .

Conditions

Interventions

TypeNameDescription
DRUGGabapentinOrthopedic Surgery was applied for the treatment of osseous disorders
OTHERPlaceboOrthopedic Surgery was applied for the treatment of osseous disorders

Timeline

Start date
2014-01-01
Primary completion
2015-01-01
Completion
2016-05-01
First posted
2016-12-29
Last updated
2016-12-29

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03005483. Inclusion in this directory is not an endorsement.